Patents by Inventor Kenneth Carson

Kenneth Carson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of vitelline protein B as a microencapsulating additive
    Patent number: 10952970
    Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: March 23, 2021
    Assignees: THE TEXAS A&M UNIVERSITY SYSTEM, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Allison R. Ficht, Kenneth Carson, Cynthia Sheffield, John Herbert Waite
  • HSP20 inhibits amyloidogenesis and neurotoxicity
    Patent number: 9802991
    Abstract: The present inventions are compositions and methods of using at least a portion of an isolated and purified ?-crystallin polypeptide that includes one or more ?-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: October 31, 2017
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Allison Ficht, Theresa Good, Kenneth Carson, Sungmun Lee
  • Use of Vitelline Protein B as a Microencapsulating Additive
    Publication number: 20170135958
    Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
    Type: Application
    Filed: January 26, 2017
    Publication date: May 18, 2017
    Inventors: Allison R. Ficht, Kenneth Carson, Cynthia Sheffield, John Herbert Waite
  • HSP20 Inhibits Amyloidogenesis and Neurotoxicity
    Publication number: 20160207971
    Abstract: The present inventions are compositions and methods of using at least a portion of an isolated and purified ?-crystallin polypeptide that includes one or more ?-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
    Type: Application
    Filed: March 18, 2016
    Publication date: July 21, 2016
    Inventors: Allison Ficht, Theresa Good, Kenneth Carson, Sungmun Lee
  • HSP20 inhibits amyloidogenesis and neurotoxicity
    Patent number: 9321817
    Abstract: The present inventions are compositions and methods of using at least a portion of an isolated and purified ?-crystallin polypeptide that includes one or more ?-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: April 26, 2016
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Allison Ficht, Theresa Good, Kenneth Carson, Sungmun Lee
  • Modulators of G protein-coupled receptor 88
    Patent number: 8497271
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: July 30, 2013
    Assignees: Bristol-Myers Squibb Company, Lexicon Pharmaceuticals, Inc.
    Inventors: Yingzhi Bi, Carolyn Diane Dzierba, Joanne J. Bronson, Kenneth Carson, Giovanni Cianchetta, Li Dong, Cynthia Fink, Michael Green, David Kimball, John E. Macor, Soojin Kwon, Jiancheng Wang, Yulian Zhang, Greg Zipp
  • Modulators of G protein-coupled receptor 88
    Patent number: 8304577
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Grant
    Filed: October 5, 2010
    Date of Patent: November 6, 2012
    Assignees: Bristol-Myers Squibb Company, Lexicon Pharmaceuticals, Inc.
    Inventors: Carolyn Diane Dzierba, Richard A. Hartz, Yingzhi Bi, Vijay T. Ahuja, Joanne J. Bronson, Kenneth Carson, Giovanni Cianchetta, Michael Green, David Kimball, S. Roy Kimura, Soojin Kwon, John E. Macor, Yulian Zhang, Greg Zipp
  • Modulators of G Protein-Coupled Receptor 88
    Publication number: 20110251196
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Application
    Filed: October 5, 2010
    Publication date: October 13, 2011
    Inventors: Carolyn Diane Dzierba, Richard A. Hartz, Yingzhi Bi, Vijay T. Ahuja, Joanne J. Bronson, Kenneth Carson, Giovanni Cianchetta, Michael Green, David Kimball, S. Roy Kimura, Soojin Kwon, John E. Macor, Yulian Zhang, Greg Zipp
  • Modulators of G Protein-Coupled Receptor 88
    Publication number: 20110245264
    Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.
    Type: Application
    Filed: October 1, 2010
    Publication date: October 6, 2011
    Inventors: Yingzhi Bi, Carolyn Diane Dzierba, Joanne J. Bronson, Kenneth Carson, Giovanni Cianchetta, Li Dong, Cynthia Fink, Michael Green, David Kimball, John E. Macor, Soojin Kwon, Jiancheng Wang, Yulian Zhang, Greg Zipp
  • Apparatus for mounting a plurality of monitors having adjustable distance to a viewer
    Patent number: 7878476
    Abstract: An apparatus and method for mounting a plurality of display monitors is disclosed, wherein the apparatus is provided at a user's desk or workstation. The apparatus can be easily moved toward and away from the user such that all the monitors mounted on the apparatus move in unison in the direction indicated by the user. Accordingly, the apparatus accommodates the visual preferences of virtually all users of the desk or workstation so that eye and skeletal muscle fatigue are reduced.
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: February 1, 2011
    Assignee: Xybix Systems, Inc.
    Inventors: Barry Carson, David Carson, Kenneth Carson
  • Imidazole-based compounds, compositions comprising them and methods of their use
    Publication number: 20070208063
    Abstract: Imidazole-based compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed.
    Type: Application
    Filed: January 25, 2007
    Publication date: September 6, 2007
    Inventors: David Augeri, Jeffrey Bagdanoff, Lakmal Boteju, Kenneth Carson, Theodore Jessop, Spencer Kimball
  • Chemokine receptor antagonists and methods of use therefor
    Publication number: 20070060592
    Abstract: Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.
    Type: Application
    Filed: November 10, 2006
    Publication date: March 15, 2007
    Inventors: Jay Luly, Yoshisuke Nakasato, Etsuo Ohshima, Geraldine Harriman, Kenneth Carson, Shomir Ghosh, Amy Elder, Karen Mattia
  • Apparatus for mounting a plurality of monitors having adjustable distance to a viewer
    Publication number: 20060238967
    Abstract: An apparatus and method for mounting a plurality of display monitors is disclosed, wherein the apparatus is provided at a user's desk or workstation. The apparatus can be easily moved toward and away from the user such that all the monitors mounted on the apparatus move in unison in the direction indicated by the user. Accordingly, the apparatus accommodates the visual preferences of virtually all users of the desk or workstation so that eye and skeletal muscle fatigue are reduced.
    Type: Application
    Filed: March 29, 2006
    Publication date: October 26, 2006
    Inventors: Barry Carson, David Carson, Kenneth Carson
  • PGD2 receptor antagonists for the treatment of inflammatory diseases
    Publication number: 20060241109
    Abstract: Disclosed are CRTH2 inhibitors represented by Structural Formula (I): The values for the variables of Structural Formula (I) are provided herein.
    Type: Application
    Filed: February 23, 2006
    Publication date: October 26, 2006
    Inventors: Jeremy Little, Shomir Ghosh, Sean Harrison, Amy Elder, Christelle Renou, Kenneth Carson
  • Compounds useful as chemokine receptor antagonists
    Publication number: 20060189628
    Abstract: The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer, and osteolytic bone disorders.
    Type: Application
    Filed: December 28, 2005
    Publication date: August 24, 2006
    Inventors: Gerard Rosse, Linli Wei, Kenneth Carson
  • Compounds useful as chemokine receptor antagonists
    Publication number: 20060172994
    Abstract: The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer or osteolytic bone disorders.
    Type: Application
    Filed: December 28, 2005
    Publication date: August 3, 2006
    Inventors: Kenneth Carson, Prakash Raman, Francois Soucy, Qing Ye, Shomir Ghosh
  • PGD2 receptor antagonists for the treatment of inflammatory diseases
    Publication number: 20060106061
    Abstract: Disclosed herein are compounds represented by Structural Formula (I): (I), wherein the variables are defined herein. Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.
    Type: Application
    Filed: December 20, 2005
    Publication date: May 18, 2006
    Inventors: Shomir Ghosh, Amy Elder, Kenneth Carson, Kevin Sprott, Sean Harrison
  • CCR1 antagonists and methods of use therefor
    Publication number: 20050288319
    Abstract: The invention provides compounds having the formula: wherein R1 is halogen. The invention also provides compositions comprising the compounds, and methods of treating diseases or disorders that comprise administering one or more of the compounds to a subject in need thereof. The disclosed compounds have CCR1 antagonist activity.
    Type: Application
    Filed: August 16, 2005
    Publication date: December 29, 2005
    Inventors: Kenneth Carson, Geraldine Harriman
  • Use of vitelline protein B as a microencapsulating additive
    Publication number: 20050260258
    Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
    Type: Application
    Filed: December 17, 2004
    Publication date: November 24, 2005
    Applicant: The Texas A&M University System
    Inventors: Allison Ficht, Kenneth Carson, John Waite, Cynthia Sheffield
  • Vehicular cell phone charger
    Patent number: D824334
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: July 31, 2018
    Inventor: Kenneth Carson